We are now enrolling dogs with osteosarcoma who have undergone amputation and chemotherapy in a study of the Canine Osteosarcoma Vaccine, Live Listeria Vector (COV-LLV), a conditionally licensed product. For participation, your dog must meet the eligibility requirements listed in the study protocol. Your veterinarian will confirm eligibility by reviewing your dog’s medical history, performing a physical exam, taking thoracic radiographs, and submitting routine blood and urine testing. All dogs enrolled in the study will be treated with the vaccine. The study has partial funding to pay for bloodwork, examinations, etc. The majority of the cost for screening and treatment and any adverse events is covered by the owner.
Primary Investigators at HopeVS: Dr. Craig Clifford, Dr. Christine Mullin, Dr. Kate Vickery, and Dr. Kristin Kicenuik
For more information please contact us: